National Health Investors (NYSE:NHI) Shares Cross Below Fifty Day Moving Average – Time to Sell?

National Health Investors, Inc. (NYSE:NHI) passed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $67.62 and traded as low as $65.30. National Health Investors shares last traded at $66.2340, with a volume of 485,523 shares traded.

National Health Investors News Summary

Investors following NHI have been watching these news items:

• Positive Sentiment: Huntington maintained a “Strong-Buy” rating and projected EPS growth from $4.76 in FY2026 to $5.00 in FY2027 and $5.27 in FY2028, offering a positive counterpoint to the downgrade. National Health Investors analyst estimates
• Neutral Sentiment: NHI adopted indemnification agreements for directors and officers. The update describes a governance measure and does not indicate a direct change to operations or financial outlook. Indemnification agreements announcement
• Negative Sentiment: Bank of America cut NHI from “Buy” to “Underperform” and lowered its price target from $86 to $67. That sharp reduction signals weaker analyst confidence and is the clearest pressure on the shares, although the new target remains above the quoted share price. Bank of America downgrade

Analyst Ratings Changes

Several research firms have recently weighed in on NHI. Truist Financial decreased their price objective on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, September 2nd. Bank of America lowered shares of National Health Investors from a “buy” rating to an “underperform” rating and dropped their target price for the company from $86.00 to $67.00 in a report on Friday. Wells Fargo & Company cut their price target on shares of National Health Investors from $78.00 to $68.00 and set an “equal weight” rating on the stock in a research report on Monday, October 19th. National Bank Financial set a $79.00 price target on shares of National Health Investors in a research report on Wednesday, September 9th. Finally, BMO Capital Markets reiterated an “outperform” rating on shares of National Health Investors in a report on Wednesday, September 23rd. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, National Health Investors currently has an average rating of “Moderate Buy” and an average price target of $79.44.

National Health Investors Stock Performance

The company has a debt-to-equity ratio of 0.50, a current ratio of 13.59 and a quick ratio of 6.78. The stock has a fifty day simple moving average of $67.30 and a two-hundred day simple moving average of $75.85. The firm has a market capitalization of $3.10 billion, a P/E ratio of 4.43, a P/E/G ratio of 4.12 and a beta of 0.51.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $10.29. The firm had revenue of $113.48 million for the quarter, compared to analysts’ expectations of $68.53 million. National Health Investors had a return on equity of 41.41% and a net margin of 152.82%. On average, research analysts predict that National Health Investors, Inc. will post 4.76 EPS for the current year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be paid a dividend of $0.92 per share. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $3.68 annualized dividend and a yield of 5.8%. National Health Investors’s dividend payout ratio is currently 26.40%.

Institutional Investors Weigh In On National Health Investors

Large investors have recently bought and sold shares of the stock. Versant Capital Management Inc raised its holdings in shares of National Health Investors by 108.5% during the third quarter. Versant Capital Management Inc now owns 415 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 216 shares during the period. Compass Wealth Management LLC acquired a new stake in shares of National Health Investors in the 3rd quarter valued at about $31,000. GAMMA Investing LLC grew its stake in shares of National Health Investors by 38.0% in the 3rd quarter. GAMMA Investing LLC now owns 603 shares of the real estate investment trust’s stock valued at $40,000 after buying an additional 166 shares during the period. Allworth Financial LP acquired a new stake in shares of National Health Investors in the 2nd quarter valued at about $42,000. Finally, EverSource Wealth Advisors LLC increased its position in National Health Investors by 34.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock valued at $51,000 after buying an additional 160 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.